Global Anti-counterfeit Pharmaceuticals and Cosmetics Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Anti-counterfeit Pharmaceuticals and Cosmetics market size was valued at US$ 16140 million in 2024 and is forecast to a readjusted size of USD 20510 million by 2031 with a CAGR of 3.5% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Anti-counterfeit Pharmaceuticals and Cosmetics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-counterfeit Pharmaceuticals and Cosmetics market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Anti-counterfeit Pharmaceuticals and Cosmetics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Anti-counterfeit Pharmaceuticals and Cosmetics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Anti-counterfeit Pharmaceuticals and Cosmetics market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-counterfeit Pharmaceuticals and Cosmetics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-counterfeit Pharmaceuticals and Cosmetics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ALIEN, AlpVision, Honeywell, Avery Dennison, Flint, SICPA, IMPINJ, Authentix, InkSure, ZEBRA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Anti-counterfeit Pharmaceuticals and Cosmetics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-counterfeit Pharmaceuticals and Cosmetics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-counterfeit Pharmaceuticals and Cosmetics, with price, sales quantity, revenue, and global market share of Anti-counterfeit Pharmaceuticals and Cosmetics from 2020 to 2025.
Chapter 3, the Anti-counterfeit Pharmaceuticals and Cosmetics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-counterfeit Pharmaceuticals and Cosmetics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Anti-counterfeit Pharmaceuticals and Cosmetics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-counterfeit Pharmaceuticals and Cosmetics.
Chapter 14 and 15, to describe Anti-counterfeit Pharmaceuticals and Cosmetics sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Anti-counterfeit Pharmaceuticals and Cosmetics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-counterfeit Pharmaceuticals and Cosmetics market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Anti-counterfeit Pharmaceuticals and Cosmetics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Anti-counterfeit Pharmaceuticals and Cosmetics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Anti-counterfeit Pharmaceuticals and Cosmetics market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-counterfeit Pharmaceuticals and Cosmetics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-counterfeit Pharmaceuticals and Cosmetics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ALIEN, AlpVision, Honeywell, Avery Dennison, Flint, SICPA, IMPINJ, Authentix, InkSure, ZEBRA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Anti-counterfeit Pharmaceuticals and Cosmetics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Anti-counterfeit Pharmaceutical
- Anti-counterfeit Cosmetics
- Pharma & Healthcare
- Cosmetics
- Others
- ALIEN
- AlpVision
- Honeywell
- Avery Dennison
- Flint
- SICPA
- IMPINJ
- Authentix
- InkSure
- ZEBRA
- LONGYING
- YONGZHENG
- TONGLI
- ZHONGCHAO
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-counterfeit Pharmaceuticals and Cosmetics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-counterfeit Pharmaceuticals and Cosmetics, with price, sales quantity, revenue, and global market share of Anti-counterfeit Pharmaceuticals and Cosmetics from 2020 to 2025.
Chapter 3, the Anti-counterfeit Pharmaceuticals and Cosmetics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-counterfeit Pharmaceuticals and Cosmetics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Anti-counterfeit Pharmaceuticals and Cosmetics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-counterfeit Pharmaceuticals and Cosmetics.
Chapter 14 and 15, to describe Anti-counterfeit Pharmaceuticals and Cosmetics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Anti-counterfeit Pharmaceutical
1.3.3 Anti-counterfeit Cosmetics
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharma & Healthcare
1.4.3 Cosmetics
1.4.4 Others
1.5 Global Anti-counterfeit Pharmaceuticals and Cosmetics Market Size & Forecast
1.5.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (2020-2031)
1.5.3 Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 ALIEN
2.1.1 ALIEN Details
2.1.2 ALIEN Major Business
2.1.3 ALIEN Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.1.4 ALIEN Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 ALIEN Recent Developments/Updates
2.2 AlpVision
2.2.1 AlpVision Details
2.2.2 AlpVision Major Business
2.2.3 AlpVision Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.2.4 AlpVision Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 AlpVision Recent Developments/Updates
2.3 Honeywell
2.3.1 Honeywell Details
2.3.2 Honeywell Major Business
2.3.3 Honeywell Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.3.4 Honeywell Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Honeywell Recent Developments/Updates
2.4 Avery Dennison
2.4.1 Avery Dennison Details
2.4.2 Avery Dennison Major Business
2.4.3 Avery Dennison Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.4.4 Avery Dennison Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Avery Dennison Recent Developments/Updates
2.5 Flint
2.5.1 Flint Details
2.5.2 Flint Major Business
2.5.3 Flint Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.5.4 Flint Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Flint Recent Developments/Updates
2.6 SICPA
2.6.1 SICPA Details
2.6.2 SICPA Major Business
2.6.3 SICPA Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.6.4 SICPA Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 SICPA Recent Developments/Updates
2.7 IMPINJ
2.7.1 IMPINJ Details
2.7.2 IMPINJ Major Business
2.7.3 IMPINJ Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.7.4 IMPINJ Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 IMPINJ Recent Developments/Updates
2.8 Authentix
2.8.1 Authentix Details
2.8.2 Authentix Major Business
2.8.3 Authentix Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.8.4 Authentix Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Authentix Recent Developments/Updates
2.9 InkSure
2.9.1 InkSure Details
2.9.2 InkSure Major Business
2.9.3 InkSure Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.9.4 InkSure Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 InkSure Recent Developments/Updates
2.10 ZEBRA
2.10.1 ZEBRA Details
2.10.2 ZEBRA Major Business
2.10.3 ZEBRA Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.10.4 ZEBRA Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 ZEBRA Recent Developments/Updates
2.11 LONGYING
2.11.1 LONGYING Details
2.11.2 LONGYING Major Business
2.11.3 LONGYING Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.11.4 LONGYING Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 LONGYING Recent Developments/Updates
2.12 YONGZHENG
2.12.1 YONGZHENG Details
2.12.2 YONGZHENG Major Business
2.12.3 YONGZHENG Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.12.4 YONGZHENG Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 YONGZHENG Recent Developments/Updates
2.13 TONGLI
2.13.1 TONGLI Details
2.13.2 TONGLI Major Business
2.13.3 TONGLI Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.13.4 TONGLI Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 TONGLI Recent Developments/Updates
2.14 ZHONGCHAO
2.14.1 ZHONGCHAO Details
2.14.2 ZHONGCHAO Major Business
2.14.3 ZHONGCHAO Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.14.4 ZHONGCHAO Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 ZHONGCHAO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTI-COUNTERFEIT PHARMACEUTICALS AND COSMETICS BY MANUFACTURER
3.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Manufacturer (2020-2025)
3.2 Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue by Manufacturer (2020-2025)
3.3 Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Anti-counterfeit Pharmaceuticals and Cosmetics by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Anti-counterfeit Pharmaceuticals and Cosmetics Manufacturer Market Share in 2024
3.4.3 Top 6 Anti-counterfeit Pharmaceuticals and Cosmetics Manufacturer Market Share in 2024
3.5 Anti-counterfeit Pharmaceuticals and Cosmetics Market: Overall Company Footprint Analysis
3.5.1 Anti-counterfeit Pharmaceuticals and Cosmetics Market: Region Footprint
3.5.2 Anti-counterfeit Pharmaceuticals and Cosmetics Market: Company Product Type Footprint
3.5.3 Anti-counterfeit Pharmaceuticals and Cosmetics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Region
4.1.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2020-2031)
4.1.2 Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2020-2031)
4.1.3 Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Region (2020-2031)
4.2 North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031)
4.3 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031)
4.4 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031)
4.5 South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031)
4.6 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
5.2 Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Type (2020-2031)
5.3 Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
6.2 Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application (2020-2031)
6.3 Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
7.2 North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
7.3 North America Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Country
7.3.1 North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2031)
7.3.2 North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
8.2 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
8.3 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Country
8.3.1 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2031)
8.3.2 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Region
9.3.1 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
10.2 South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
10.3 South America Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Country
10.3.1 South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2031)
10.3.2 South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Country
11.3.1 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Anti-counterfeit Pharmaceuticals and Cosmetics Market Drivers
12.2 Anti-counterfeit Pharmaceuticals and Cosmetics Market Restraints
12.3 Anti-counterfeit Pharmaceuticals and Cosmetics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Anti-counterfeit Pharmaceuticals and Cosmetics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-counterfeit Pharmaceuticals and Cosmetics
13.3 Anti-counterfeit Pharmaceuticals and Cosmetics Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-counterfeit Pharmaceuticals and Cosmetics Typical Distributors
14.3 Anti-counterfeit Pharmaceuticals and Cosmetics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. ALIEN Basic Information, Manufacturing Base and Competitors
Table 4. ALIEN Major Business
Table 5. ALIEN Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 6. ALIEN Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. ALIEN Recent Developments/Updates
Table 8. AlpVision Basic Information, Manufacturing Base and Competitors
Table 9. AlpVision Major Business
Table 10. AlpVision Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 11. AlpVision Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. AlpVision Recent Developments/Updates
Table 13. Honeywell Basic Information, Manufacturing Base and Competitors
Table 14. Honeywell Major Business
Table 15. Honeywell Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 16. Honeywell Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Honeywell Recent Developments/Updates
Table 18. Avery Dennison Basic Information, Manufacturing Base and Competitors
Table 19. Avery Dennison Major Business
Table 20. Avery Dennison Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 21. Avery Dennison Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Avery Dennison Recent Developments/Updates
Table 23.Flint Basic Information, Manufacturing Base and Competitors
Table 24.Flint Major Business
Table 25.Flint Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 26.Flint Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27.Flint Recent Developments/Updates
Table 28. SICPA Basic Information, Manufacturing Base and Competitors
Table 29. SICPA Major Business
Table 30. SICPA Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 31. SICPA Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. SICPA Recent Developments/Updates
Table 33. IMPINJ Basic Information, Manufacturing Base and Competitors
Table 34. IMPINJ Major Business
Table 35. IMPINJ Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 36. IMPINJ Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. IMPINJ Recent Developments/Updates
Table 38. Authentix Basic Information, Manufacturing Base and Competitors
Table 39. Authentix Major Business
Table 40. Authentix Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 41. Authentix Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Authentix Recent Developments/Updates
Table 43. InkSure Basic Information, Manufacturing Base and Competitors
Table 44. InkSure Major Business
Table 45. InkSure Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 46. InkSure Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. InkSure Recent Developments/Updates
Table 48. ZEBRA Basic Information, Manufacturing Base and Competitors
Table 49. ZEBRA Major Business
Table 50. ZEBRA Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 51. ZEBRA Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. ZEBRA Recent Developments/Updates
Table 53. LONGYING Basic Information, Manufacturing Base and Competitors
Table 54. LONGYING Major Business
Table 55. LONGYING Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 56. LONGYING Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. LONGYING Recent Developments/Updates
Table 58. YONGZHENG Basic Information, Manufacturing Base and Competitors
Table 59. YONGZHENG Major Business
Table 60. YONGZHENG Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 61. YONGZHENG Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. YONGZHENG Recent Developments/Updates
Table 63.TONGLI Basic Information, Manufacturing Base and Competitors
Table 64.TONGLI Major Business
Table 65.TONGLI Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 66.TONGLI Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67.TONGLI Recent Developments/Updates
Table 68. ZHONGCHAO Basic Information, Manufacturing Base and Competitors
Table 69. ZHONGCHAO Major Business
Table 70. ZHONGCHAO Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 71. ZHONGCHAO Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. ZHONGCHAO Recent Developments/Updates
Table 73. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Manufacturer (2020-2025) & (K Pcs)
Table 74. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue by Manufacturer (2020-2025) & (USD Million)
Table 75. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Manufacturer (2020-2025) & (USD/Pcs)
Table 76. Market Position of Manufacturers in Anti-counterfeit Pharmaceuticals and Cosmetics, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 77. Head Office and Anti-counterfeit Pharmaceuticals and Cosmetics Production Site of Key Manufacturer
Table 78. Anti-counterfeit Pharmaceuticals and Cosmetics Market: Company ProductTypeFootprint
Table 79. Anti-counterfeit Pharmaceuticals and Cosmetics Market: Company Product ApplicationFootprint
Table 80. Anti-counterfeit Pharmaceuticals and Cosmetics New Market Entrants and Barriers to Market Entry
Table 81. Anti-counterfeit Pharmaceuticals and Cosmetics Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 83. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2020-2025) & (K Pcs)
Table 84. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2026-2031) & (K Pcs)
Table 85. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2020-2025) & (USD Million)
Table 86. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2026-2031) & (USD Million)
Table 87. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Region (2020-2025) & (USD/Pcs)
Table 88. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Region (2026-2031) & (USD/Pcs)
Table 89. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 90. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 91. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value byType (2020-2025) & (USD Million)
Table 92. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value byType (2026-2031) & (USD Million)
Table 93. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price byType (2020-2025) & (USD/Pcs)
Table 94. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price byType (2026-2031) & (USD/Pcs)
Table 95. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 96. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 97. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application (2020-2025) & (USD Million)
Table 98. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application (2026-2031) & (USD Million)
Table 99. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Application (2020-2025) & (USD/Pcs)
Table 100. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Application (2026-2031) & (USD/Pcs)
Table 101. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 102. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 103. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 104. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 105. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2025) & (K Pcs)
Table 106. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2026-2031) & (K Pcs)
Table 107. North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 110. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 111. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 112. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 113. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2025) & (K Pcs)
Table 114. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2026-2031) & (K Pcs)
Table 115. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2025) & (USD Million)
Table 116. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 118. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 119. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 120. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 121. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2020-2025) & (K Pcs)
Table 122. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2026-2031) & (K Pcs)
Table 123. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2020-2025) & (USD Million)
Table 124. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2026-2031) & (USD Million)
Table 125. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 126. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 127. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 128. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 129. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2025) & (K Pcs)
Table 130. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2026-2031) & (K Pcs)
Table 131. South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2025) & (USD Million)
Table 132. South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 134. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 135. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 136. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 137. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2025) & (K Pcs)
Table 138. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2026-2031) & (K Pcs)
Table 139. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2025) & (USD Million)
Table 140. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2026-2031) & (USD Million)
Table 141. Anti-counterfeit Pharmaceuticals and Cosmetics Raw Material
Table 142. Key Manufacturers of Anti-counterfeit Pharmaceuticals and Cosmetics Raw Materials
Table 143. Anti-counterfeit Pharmaceuticals and CosmeticsTypical Distributors
Table 144. Anti-counterfeit Pharmaceuticals and CosmeticsTypical Customers
LIST OFFIGURES
Figure 1. Anti-counterfeit Pharmaceuticals and Cosmetics Picture
Figure 2. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue Market Share byType in 2024
Figure 4. Anti-counterfeit Pharmaceutical Examples
Figure 5. Anti-counterfeit Cosmetics Examples
Figure 6. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue Market Share by Application in 2024
Figure 8. Pharma & Healthcare Examples
Figure 9. Cosmetics Examples
Figure 10. Others Examples
Figure 11. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value andForecast (2020-2031) & (USD Million)
Figure 13. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (2020-2031) & (K Pcs)
Figure 14. Global Anti-counterfeit Pharmaceuticals and Cosmetics Price (2020-2031) & (USD/Pcs)
Figure 15. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Anti-counterfeit Pharmaceuticals and Cosmetics by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18.Top 3 Anti-counterfeit Pharmaceuticals and Cosmetics Manufacturer (Revenue) Market Share in 2024
Figure 19.Top 6 Anti-counterfeit Pharmaceuticals and Cosmetics Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 28. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share byType (2020-2031)
Figure 29. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price byType (2020-2031) & (USD/Pcs)
Figure 30. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue Market Share by Application (2020-2031)
Figure 32. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Application (2020-2031) & (USD/Pcs)
Figure 33. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 34. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 41. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 45.France Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 50. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Region (2020-2031)
Figure 53. China Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 56. India Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 60. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 66. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Country (2020-2031)
Figure 69.Turkey Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 73. Anti-counterfeit Pharmaceuticals and Cosmetics Market Drivers
Figure 74. Anti-counterfeit Pharmaceuticals and Cosmetics Market Restraints
Figure 75. Anti-counterfeit Pharmaceuticals and Cosmetics MarketTrends
Figure 76. PortersFiveForces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Anti-counterfeit Pharmaceuticals and Cosmetics in 2024
Figure 78. Manufacturing Process Analysis of Anti-counterfeit Pharmaceuticals and Cosmetics
Figure 79. Anti-counterfeit Pharmaceuticals and Cosmetics Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Anti-counterfeit Pharmaceutical
1.3.3 Anti-counterfeit Cosmetics
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharma & Healthcare
1.4.3 Cosmetics
1.4.4 Others
1.5 Global Anti-counterfeit Pharmaceuticals and Cosmetics Market Size & Forecast
1.5.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (2020-2031)
1.5.3 Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 ALIEN
2.1.1 ALIEN Details
2.1.2 ALIEN Major Business
2.1.3 ALIEN Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.1.4 ALIEN Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 ALIEN Recent Developments/Updates
2.2 AlpVision
2.2.1 AlpVision Details
2.2.2 AlpVision Major Business
2.2.3 AlpVision Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.2.4 AlpVision Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 AlpVision Recent Developments/Updates
2.3 Honeywell
2.3.1 Honeywell Details
2.3.2 Honeywell Major Business
2.3.3 Honeywell Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.3.4 Honeywell Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Honeywell Recent Developments/Updates
2.4 Avery Dennison
2.4.1 Avery Dennison Details
2.4.2 Avery Dennison Major Business
2.4.3 Avery Dennison Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.4.4 Avery Dennison Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Avery Dennison Recent Developments/Updates
2.5 Flint
2.5.1 Flint Details
2.5.2 Flint Major Business
2.5.3 Flint Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.5.4 Flint Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Flint Recent Developments/Updates
2.6 SICPA
2.6.1 SICPA Details
2.6.2 SICPA Major Business
2.6.3 SICPA Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.6.4 SICPA Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 SICPA Recent Developments/Updates
2.7 IMPINJ
2.7.1 IMPINJ Details
2.7.2 IMPINJ Major Business
2.7.3 IMPINJ Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.7.4 IMPINJ Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 IMPINJ Recent Developments/Updates
2.8 Authentix
2.8.1 Authentix Details
2.8.2 Authentix Major Business
2.8.3 Authentix Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.8.4 Authentix Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Authentix Recent Developments/Updates
2.9 InkSure
2.9.1 InkSure Details
2.9.2 InkSure Major Business
2.9.3 InkSure Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.9.4 InkSure Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 InkSure Recent Developments/Updates
2.10 ZEBRA
2.10.1 ZEBRA Details
2.10.2 ZEBRA Major Business
2.10.3 ZEBRA Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.10.4 ZEBRA Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 ZEBRA Recent Developments/Updates
2.11 LONGYING
2.11.1 LONGYING Details
2.11.2 LONGYING Major Business
2.11.3 LONGYING Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.11.4 LONGYING Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 LONGYING Recent Developments/Updates
2.12 YONGZHENG
2.12.1 YONGZHENG Details
2.12.2 YONGZHENG Major Business
2.12.3 YONGZHENG Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.12.4 YONGZHENG Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 YONGZHENG Recent Developments/Updates
2.13 TONGLI
2.13.1 TONGLI Details
2.13.2 TONGLI Major Business
2.13.3 TONGLI Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.13.4 TONGLI Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 TONGLI Recent Developments/Updates
2.14 ZHONGCHAO
2.14.1 ZHONGCHAO Details
2.14.2 ZHONGCHAO Major Business
2.14.3 ZHONGCHAO Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
2.14.4 ZHONGCHAO Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 ZHONGCHAO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTI-COUNTERFEIT PHARMACEUTICALS AND COSMETICS BY MANUFACTURER
3.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Manufacturer (2020-2025)
3.2 Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue by Manufacturer (2020-2025)
3.3 Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Anti-counterfeit Pharmaceuticals and Cosmetics by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Anti-counterfeit Pharmaceuticals and Cosmetics Manufacturer Market Share in 2024
3.4.3 Top 6 Anti-counterfeit Pharmaceuticals and Cosmetics Manufacturer Market Share in 2024
3.5 Anti-counterfeit Pharmaceuticals and Cosmetics Market: Overall Company Footprint Analysis
3.5.1 Anti-counterfeit Pharmaceuticals and Cosmetics Market: Region Footprint
3.5.2 Anti-counterfeit Pharmaceuticals and Cosmetics Market: Company Product Type Footprint
3.5.3 Anti-counterfeit Pharmaceuticals and Cosmetics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Region
4.1.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2020-2031)
4.1.2 Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2020-2031)
4.1.3 Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Region (2020-2031)
4.2 North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031)
4.3 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031)
4.4 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031)
4.5 South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031)
4.6 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
5.2 Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Type (2020-2031)
5.3 Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
6.2 Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application (2020-2031)
6.3 Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
7.2 North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
7.3 North America Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Country
7.3.1 North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2031)
7.3.2 North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
8.2 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
8.3 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Country
8.3.1 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2031)
8.3.2 Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Region
9.3.1 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
10.2 South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
10.3 South America Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Country
10.3.1 South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2031)
10.3.2 South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Market Size by Country
11.3.1 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Anti-counterfeit Pharmaceuticals and Cosmetics Market Drivers
12.2 Anti-counterfeit Pharmaceuticals and Cosmetics Market Restraints
12.3 Anti-counterfeit Pharmaceuticals and Cosmetics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Anti-counterfeit Pharmaceuticals and Cosmetics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-counterfeit Pharmaceuticals and Cosmetics
13.3 Anti-counterfeit Pharmaceuticals and Cosmetics Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-counterfeit Pharmaceuticals and Cosmetics Typical Distributors
14.3 Anti-counterfeit Pharmaceuticals and Cosmetics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. ALIEN Basic Information, Manufacturing Base and Competitors
Table 4. ALIEN Major Business
Table 5. ALIEN Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 6. ALIEN Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. ALIEN Recent Developments/Updates
Table 8. AlpVision Basic Information, Manufacturing Base and Competitors
Table 9. AlpVision Major Business
Table 10. AlpVision Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 11. AlpVision Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. AlpVision Recent Developments/Updates
Table 13. Honeywell Basic Information, Manufacturing Base and Competitors
Table 14. Honeywell Major Business
Table 15. Honeywell Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 16. Honeywell Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Honeywell Recent Developments/Updates
Table 18. Avery Dennison Basic Information, Manufacturing Base and Competitors
Table 19. Avery Dennison Major Business
Table 20. Avery Dennison Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 21. Avery Dennison Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Avery Dennison Recent Developments/Updates
Table 23.Flint Basic Information, Manufacturing Base and Competitors
Table 24.Flint Major Business
Table 25.Flint Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 26.Flint Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27.Flint Recent Developments/Updates
Table 28. SICPA Basic Information, Manufacturing Base and Competitors
Table 29. SICPA Major Business
Table 30. SICPA Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 31. SICPA Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. SICPA Recent Developments/Updates
Table 33. IMPINJ Basic Information, Manufacturing Base and Competitors
Table 34. IMPINJ Major Business
Table 35. IMPINJ Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 36. IMPINJ Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. IMPINJ Recent Developments/Updates
Table 38. Authentix Basic Information, Manufacturing Base and Competitors
Table 39. Authentix Major Business
Table 40. Authentix Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 41. Authentix Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Authentix Recent Developments/Updates
Table 43. InkSure Basic Information, Manufacturing Base and Competitors
Table 44. InkSure Major Business
Table 45. InkSure Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 46. InkSure Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. InkSure Recent Developments/Updates
Table 48. ZEBRA Basic Information, Manufacturing Base and Competitors
Table 49. ZEBRA Major Business
Table 50. ZEBRA Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 51. ZEBRA Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. ZEBRA Recent Developments/Updates
Table 53. LONGYING Basic Information, Manufacturing Base and Competitors
Table 54. LONGYING Major Business
Table 55. LONGYING Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 56. LONGYING Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. LONGYING Recent Developments/Updates
Table 58. YONGZHENG Basic Information, Manufacturing Base and Competitors
Table 59. YONGZHENG Major Business
Table 60. YONGZHENG Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 61. YONGZHENG Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. YONGZHENG Recent Developments/Updates
Table 63.TONGLI Basic Information, Manufacturing Base and Competitors
Table 64.TONGLI Major Business
Table 65.TONGLI Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 66.TONGLI Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67.TONGLI Recent Developments/Updates
Table 68. ZHONGCHAO Basic Information, Manufacturing Base and Competitors
Table 69. ZHONGCHAO Major Business
Table 70. ZHONGCHAO Anti-counterfeit Pharmaceuticals and Cosmetics Product and Services
Table 71. ZHONGCHAO Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. ZHONGCHAO Recent Developments/Updates
Table 73. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Manufacturer (2020-2025) & (K Pcs)
Table 74. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue by Manufacturer (2020-2025) & (USD Million)
Table 75. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Manufacturer (2020-2025) & (USD/Pcs)
Table 76. Market Position of Manufacturers in Anti-counterfeit Pharmaceuticals and Cosmetics, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 77. Head Office and Anti-counterfeit Pharmaceuticals and Cosmetics Production Site of Key Manufacturer
Table 78. Anti-counterfeit Pharmaceuticals and Cosmetics Market: Company ProductTypeFootprint
Table 79. Anti-counterfeit Pharmaceuticals and Cosmetics Market: Company Product ApplicationFootprint
Table 80. Anti-counterfeit Pharmaceuticals and Cosmetics New Market Entrants and Barriers to Market Entry
Table 81. Anti-counterfeit Pharmaceuticals and Cosmetics Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 83. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2020-2025) & (K Pcs)
Table 84. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2026-2031) & (K Pcs)
Table 85. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2020-2025) & (USD Million)
Table 86. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2026-2031) & (USD Million)
Table 87. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Region (2020-2025) & (USD/Pcs)
Table 88. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Region (2026-2031) & (USD/Pcs)
Table 89. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 90. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 91. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value byType (2020-2025) & (USD Million)
Table 92. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value byType (2026-2031) & (USD Million)
Table 93. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price byType (2020-2025) & (USD/Pcs)
Table 94. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price byType (2026-2031) & (USD/Pcs)
Table 95. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 96. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 97. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application (2020-2025) & (USD Million)
Table 98. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application (2026-2031) & (USD Million)
Table 99. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Application (2020-2025) & (USD/Pcs)
Table 100. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Application (2026-2031) & (USD/Pcs)
Table 101. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 102. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 103. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 104. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 105. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2025) & (K Pcs)
Table 106. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2026-2031) & (K Pcs)
Table 107. North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 110. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 111. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 112. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 113. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2025) & (K Pcs)
Table 114. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2026-2031) & (K Pcs)
Table 115. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2025) & (USD Million)
Table 116. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 118. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 119. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 120. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 121. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2020-2025) & (K Pcs)
Table 122. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Region (2026-2031) & (K Pcs)
Table 123. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2020-2025) & (USD Million)
Table 124. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Region (2026-2031) & (USD Million)
Table 125. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 126. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 127. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 128. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 129. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2025) & (K Pcs)
Table 130. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2026-2031) & (K Pcs)
Table 131. South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2025) & (USD Million)
Table 132. South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2020-2025) & (K Pcs)
Table 134. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity byType (2026-2031) & (K Pcs)
Table 135. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2020-2025) & (K Pcs)
Table 136. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Application (2026-2031) & (K Pcs)
Table 137. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2020-2025) & (K Pcs)
Table 138. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity by Country (2026-2031) & (K Pcs)
Table 139. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2020-2025) & (USD Million)
Table 140. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Country (2026-2031) & (USD Million)
Table 141. Anti-counterfeit Pharmaceuticals and Cosmetics Raw Material
Table 142. Key Manufacturers of Anti-counterfeit Pharmaceuticals and Cosmetics Raw Materials
Table 143. Anti-counterfeit Pharmaceuticals and CosmeticsTypical Distributors
Table 144. Anti-counterfeit Pharmaceuticals and CosmeticsTypical Customers
LIST OFFIGURES
Figure 1. Anti-counterfeit Pharmaceuticals and Cosmetics Picture
Figure 2. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue Market Share byType in 2024
Figure 4. Anti-counterfeit Pharmaceutical Examples
Figure 5. Anti-counterfeit Cosmetics Examples
Figure 6. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue Market Share by Application in 2024
Figure 8. Pharma & Healthcare Examples
Figure 9. Cosmetics Examples
Figure 10. Others Examples
Figure 11. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value andForecast (2020-2031) & (USD Million)
Figure 13. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity (2020-2031) & (K Pcs)
Figure 14. Global Anti-counterfeit Pharmaceuticals and Cosmetics Price (2020-2031) & (USD/Pcs)
Figure 15. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Anti-counterfeit Pharmaceuticals and Cosmetics by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18.Top 3 Anti-counterfeit Pharmaceuticals and Cosmetics Manufacturer (Revenue) Market Share in 2024
Figure 19.Top 6 Anti-counterfeit Pharmaceuticals and Cosmetics Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 28. Global Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share byType (2020-2031)
Figure 29. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price byType (2020-2031) & (USD/Pcs)
Figure 30. Global Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Anti-counterfeit Pharmaceuticals and Cosmetics Revenue Market Share by Application (2020-2031)
Figure 32. Global Anti-counterfeit Pharmaceuticals and Cosmetics Average Price by Application (2020-2031) & (USD/Pcs)
Figure 33. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 34. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 41. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 45.France Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 50. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Region (2020-2031)
Figure 53. China Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 56. India Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 60. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share byType (2020-2031)
Figure 66. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value Market Share by Country (2020-2031)
Figure 69.Turkey Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Anti-counterfeit Pharmaceuticals and Cosmetics Consumption Value (2020-2031) & (USD Million)
Figure 73. Anti-counterfeit Pharmaceuticals and Cosmetics Market Drivers
Figure 74. Anti-counterfeit Pharmaceuticals and Cosmetics Market Restraints
Figure 75. Anti-counterfeit Pharmaceuticals and Cosmetics MarketTrends
Figure 76. PortersFiveForces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Anti-counterfeit Pharmaceuticals and Cosmetics in 2024
Figure 78. Manufacturing Process Analysis of Anti-counterfeit Pharmaceuticals and Cosmetics
Figure 79. Anti-counterfeit Pharmaceuticals and Cosmetics Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
More Publications
Global Holographic Anti-Counterfeiting Marks Market 2026 by Company, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
January 2026
155 pages
